The study of over 87,000 matched patients 65 and up also found 28% fewer liver decompensation events, but no drop in heart attack or stroke and more osteoporosis diagnoses.
Recap by typeshit. Full story at Managed Healthcare Executive.
18:05
Dr. Stirrett walks through three pointers for people on tirzepatide, framed as part of a broader GLP-1 guide. His advice, not a set protocol.
He walks through an Azoury et al study in the October 2026 Plastic and Reconstructive Surgery that uses global health network data to compare the two weight loss routes.
The claim credits GLP-1 drugs' effects on insulin sensitivity and inflammation for changes in dermatologic conditions. No study is cited.
U of T researchers built the AI tool with the aim of speeding up how new peptide drugs are found. The university's announcement has the details.
The two actors chat about what keeps them working, how they approach fitness, and look back on Mona Singh's show Jassi Jaissi Koi Nahin.
A local TV health segment on safety when using peptide therapy and GLP-1 drugs, aimed at men's health.
Loading…